HuGE Literature Finder
Records
1
-
14
| TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India. BMC gastroenterology 2021 Aug 21 (1): 327. Grover Narinder, Bhatia Prateek, Kumar Antriksh, Singh Minu, Lad Deepesh, Mandavdhare Harshal S, Samanta Jayanta, Prasad Kaushal K, Dutta Usha, Sharma Vish |
| HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 2017 Dec . Wilson A, Jansen L E, Rose R V, Gregor J C, Ponich T, Chande N, Khanna R, Yan B, Jairath V, Khanna N, Sey M, Beaton M, McIntosh K, Teft W A, Kim R |
| Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease. Journal of population therapeutics and clinical pharmacology = Journal de la the?rapeutique des populations et de la pharamcologie clinique 2016 23 (1): e26-36. Al-Judaibi B, Schwarz U I, Huda N, Dresser G K, Gregor J C, Ponich T, Chande N, Mosli M, Kim R |
| TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. Advances in medical sciences 2015 Dec 61 (1): 135-140. Steponaitiene Ruta, Kupcinskas Juozas, Survilaite Santa, Varkalaite Greta, Jonaitis Laimas, Kiudelis Gediminas, Denapiene Goda, Valantinas Jonas, Skieceviciene Jurgita, Kupcinskas Lim |
| Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis. PloS one 2015 10 (3): e0121745. Liu Yue-Ping, Wu Hai-Yan, Yang Xiang, Xu Han-Qing, Li Yong-Chuan, Shi Da-Chuan, Huang Jun-Fu, Huang Qing, Fu Wei-Li |
| Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients. World journal of gastroenterology : WJG 2014 Mar 20 (12): 3327-34. Carvalho Ana Teresa P, Esberard Barbara C, Fróes Renata S B, Rapozo Davy C M, Grinman Ana B, Simão Tatiana A, Santos Juliana C V C, Carneiro Antonio José V, Ribeiro-Pinto Luis Felipe, de Souza Heitor S |
| Risk factors for serious adverse effects of thiopurines in patients with Crohn's disease. Current drug safety 2013 Jul 8 (3): 181-5. Mazor Yoav, Koifman Eduard, Elkin Hela, Chowers Yehuda, Krivoy Norberto, Karban Amir, Efrati Ed |
| Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease. World journal of gastroenterology : WJG 2010 Jul 16 (25): 3187-95. Dong Xian-Wen, Zheng Qing, Zhu Ming-Ming, Tong Jing-Lu, Ran Zhi-H |
| Pharmacogenetics of thiopurine therapy in paediatric IBD patients. Alimentary pharmacology & therapeutics 2006 Apr 23 (8): 1137-41. De Ridder L, Van Dieren J M, Van Deventer H J H, Stokkers P C F, Van der Woude J C J, Van Vuuren A J, Benninga M A, Escher J C, Hommes D |
| Thiopurine methyltransferase (TPMT) heterozygosity and enzyme activity as predictive tests for the development of azathioprine-related adverse events. Journal of the neurological sciences 2005 Apr 231 (1-2): 71-80. Heckmann Jeannine M, Lambson Elisabetta M T, Little Francesca, Owen Elizabeth |
| Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics 2004 Nov 14 (11): 779-81. Gearry Richard B, Roberts Rebecca L, Barclay Murray L, Kennedy Martin |
| Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 2004 Mar 14 (3): 181-7. Marinaki Anthony M, Ansari Azhar, Duley John A, Arenas Monica, Sumi Satoshi, Lewis Cathryn M, Shobowale-Bakre El-Monsor, Escuredo Emilia, Fairbanks Lynette D, Sanderson Jeremy |
| Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 2003 Aug 18 (4): 395-400. Gearry R B, Barclay M L, Burt M J, Collett J A, Chapman B A, Roberts R L, Kennedy M |
| Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 2002 Aug 12 (6): 429-36. Schwab Matthias, Schäffeler Elke, Marx Claudia, Fischer Christine, Lang Thomas, Behrens Christoph, Gregor Michael, Eichelbaum Michel, Zanger Ulrich M, Kaskas Bernd |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 24, 2022
- Content source: